We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+19.96%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.24%
AUM
$13.1B
AUM Growth
+$1.42B
(+12%)
Cap. Flow
-$642M
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
18.52%
Holding
284
New
44
Increased
49
Reduced
142
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$163M |
| 2 |
Caterpillar
CAT
|
+$85.4M |
| 3 |
Analog Devices
ADI
|
+$53.7M |
| 4 |
Advance Auto Parts
AAP
|
+$39.7M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$37.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$142M |
| 2 |
Costco
COST
|
+$77.5M |
| 3 |
Vail Resorts
MTN
|
+$76.9M |
| 4 |
CELG
Celgene Corp
CELG
|
+$73.2M |
| 5 |
Mettler-Toledo International
MTD
|
+$67.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.26% |
| 2 | Healthcare | 16.35% |
| 3 | Consumer Discretionary | 13.11% |
| 4 | Industrials | 12.97% |
| 5 | Financials | 10.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.89T
| $365M | 2.78% |
7,690,888
-413,792
| -5% | -$17.6M |
|
2
Amazon
AMZN
$2.5T
| $351M | 2.67% |
3,941,480
-110,720
| -3% | -$9.21M |
|
3
Microsoft
MSFT
$2.84T
| $252M | 1.92% |
2,139,797
-23,428
| -1% | -$2.56M |
|
4
Visa
V
$677B
| $232M | 1.77% |
1,487,673
-88,048
| -6% | -$12.7M |
|
5
Boeing
BA
$165B
| $220M | 1.67% |
575,535
-43,000
| -7% | -$16.6M |
|
6
ServiceNow
NOW
$102B
| $217M | 1.65% |
4,396,220
-912,315
| -17% | -$40.1M |
|
7
Alphabet (Google) Class C
GOOG
$3.9T
| $214M | 1.63% |
3,644,820
-262,460
| -7% | -$14.7M |
|
8
UnitedHealth
UNH
$382B
| $197M | 1.5% |
794,857
-61,232
| -7% | -$15.6M |
|
9
Home Depot
HD
$332B
| $194M | 1.48% |
1,010,900
+133,049
| +15% | +$24.4M |
|
10
Salesforce
CRM
$134B
| $192M | 1.46% |
1,210,925
-87,594
| -7% | -$13.6M |
|
|
11
Mettler-Toledo International
MTD
$26.8B
| $186M | 1.42% |
257,237
-103,391
| -29% | -$67.2M |
|
12
Marathon Petroleum
MPC
$90.3B
| $178M | 1.35% |
2,973,677
-9,230
| -0.3% | -$581K |
|
13
Ametek
AME
$55.5B
| $174M | 1.32% |
2,095,323
-353,687
| -14% | -$26.9M |
|
|
14
Alphabet (Google) Class A
GOOGL
$3.91T
| $171M | 1.3% |
2,907,400
-216,020
| -7% | -$12.2M |
|
|
15
Bristol-Myers Squibb
BMY
$127B
| $156M | 1.19% |
+3,278,241
| New | +$163M |
|
16
Teledyne Technologies
TDY
$30.4B
| $156M | 1.18% |
656,538
-10,694
| -2% | -$2.42M |
|
17
Trane Technologies
TT
$106B
| $152M | 1.16% |
1,409,211
+35,928
| +3% | +$3.64M |
|
18
Cooper Companies
COO
$13.7B
| $151M | 1.15% |
2,044,188
-469,520
| -19% | -$32.8M |
|
|
MDCO
19
DELISTED
Medicines Co
MDCO
| $148M | 1.13% |
5,290,481
+685,762
| +15% | +$16.2M |
|
20
Netflix
NFLX
$292B
| $142M | 1.08% |
3,980,840
-39,670
| -1% | -$1.38M |
|
21
TransDigm Group
TDG
$69.2B
| $136M | 1.03% |
299,044
-3,277
| -1% | -$1.33M |
|
22
Vertex Pharmaceuticals
VRTX
$121B
| $125M | 0.96% |
682,226
+39,336
| +6% | +$7.27M |
|
23
Marriott International
MAR
$98.7B
| $125M | 0.95% |
1,000,070
+207,423
| +26% | +$24.4M |
|
24
Thermo Fisher Scientific
TMO
$211B
| $125M | 0.95% |
456,640
-31,464
| -6% | -$7.83M |
|
25
Mastercard
MA
$477B
| $119M | 0.91% |
506,625
-27,982
| -5% | -$6.02M |
|
Similar funds
OAG
JG
CHP
SAM
Westfield Capital Management's Q1 2019 Portfolio in Review
As of Q1 2019, Westfield Capital Management held 284 positions worth $13.1B, up 12% from $11.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Westfield Capital Management withdrew a net $642M in Q1 2019, closing 38 positions and reducing 142 holdings. Its most notable exit was Jazz Pharmaceuticals, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Westfield Capital Management opened a new position in Bristol-Myers Squibb worth $156M.
- Westfield Capital Management's largest Q1 2019 buy was Bristol-Myers Squibb: 3,278,241 shares worth $156M.
- Westfield Capital Management added most to T-Mobile US in Q1 2019, an estimated $32.3M increase.
- Westfield Capital Management's biggest Q1 2019 reduction was Vail Resorts, cutting an estimated $76.9M.
- Westfield Capital Management fully exited Jazz Pharmaceuticals in Q1 2019, selling an estimated $142M.
- Westfield Capital Management's ten largest holdings make up 19% of its $13.1B portfolio in Q1 2019.
- Westfield Capital Management opened 44 new positions and closed 38 in Q1 2019.
- Westfield Capital Management's portfolio value rose 12% quarter-over-quarter to $13.1B.
Based on Westfield Capital Management's 13F filing for Q1 2019, filed 14 May 2019.